Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study (Q46660489)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2005

Language	Label	Description	Also known as
English	Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study	scientific article published in August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Martin Schrappe

14

object named as

Martin Schrappe

1 reference

Europe PubMed Central

24 December 2017

Thomas Klingebiel

5

object named as

Thomas Klingebiel

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Maria Grazia Valsecchi

2

object named as

Maria Grazia Valsecchi

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

7

object named as

Jan Stary

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Christina Peters

6

object named as

Christina Peters

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

author name string

Adriana Balduzzi

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Cornelio Uderzo

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Paola De Lorenzo

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Maria S Felice

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Edina Magyarosy

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Valentino Conter

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Alfred Reiter

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Chiara Messina

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Helmut Gadner

13

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

366

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

9486

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

635-642

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966998-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)66998-X

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

release_hnghtuzelnfb3hc5miq2lurxlu

1 reference

https://api.fatcat.wiki/v0/release/hnghtuzelnfb3hc5miq2lurxlu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16112299

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46660489&oldid=2125063667"